Combo Attack III is one of the many Pictos you can acquire in Clair Obscur: Expedition 33, but where can you find it and what does it do? This page acts as a comprehensive breakdown of the Combo ...

In its 15th year, Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination treatment of avutometinib and defactinib for a rare form of ovarian cancer.

The trial tested two different radiotherapy strategies—short and long-course regimes—in combination with durvalumab, a common immunotherapy treatment. For patients reaching the end of ...

May 9, 2025 -- A new oral cancer drug combination has gained a quick federal nod after clinical trials found that it provides significant and longer-lasting relief for a rare ovarian cancer that ...

AVMAPKI plus FAKZYNJA is only commercially available in the U.S. as an oral combination co-pack with the two prescription products, known as "AVMAPKI FAKZYNJA CO-PACK." "Today’s approval of ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy without increasing the risk of severe lung inflammation (pneumonitis).

What are the Alone in the Dark combination lock solutions? We've been here before. While Alone in the Dark is very much its own game, it's easy to draw similarities to other genre stalwarts like ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

After accounting for the Veren combination and the non-strategic asset dispositions, we are increasing our average 2025 production forecast to 295,000 – 300,000 boe/d (63% liquids) on capital ...

The FDA has granted accelerated approval to Verastem’s FAK inhibitor defactinib (Fakzynja) in combination with its MEK inhibitor avutometinib (Avmapki) for KRAS-mutated recurrent low-grade ...

Verastem Oncology said the Food and Drug Administration approved the combination of avutometinib capsules and defactinib tablets for certain patients with KRAS-mutated recurrent low-grade serous ...